Hence, this study compared the original PEPI to a modified p-PgR status alone and a modified PEPI including the PgR status (PEPI-P) as a prognostic factor for NAE in postmenopausal patients with ER-positive and HER2-negative breast cancer. The gene discussed is PGR; the disease is breast cancer.